Background illustration for clinical trials search

Paid Clinical Trials Mobile

Discover 179 paid clinical trials in Mobile, Alabama. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

for
Ovarian Cancer
Location: Mobile AL, Jackson MS, Gainesville GA, Shreveport LA,
Sponsor: Incyte Corporation

Sex: Female

Age: 18 - 70+

Code: NCT07023627

Phase 2, Recruiting

Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers

for
Pancreatic Neoplasm
Location: Mobile AL, Baton Rouge LA, Birmingham AL, Atlanta GA,
Sponsor: ECOG-ACRIN Cancer Research Group

Sex: All

Age: 50 - 70+

Code: NCT04239573

Recruiting

A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

for
Endometrial Cancer
Location: Mobile AL, Covington LA, Jackson MS, Chattanooga TN,
Sponsor: Merck Sharp & Dohme LLC

Sex: Female

Age: 18+

Code: NCT06952504

Phase 3, Recruiting

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

for
Advanced Malignant Solid Neoplasm,
Location: Mobile AL, Gulfport MS, New Orleans LA, Metairie LA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0+

Code: NCT05564377

Phase 2, Recruiting

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

for
Cutaneous Melanoma, Stage II
Location: Mobile AL, Atlanta GA, Little Rock AR, Jacksonville FL,
Sponsor: Melanoma and Skin Cancer Trials Limited

Sex: All

Age: 18+

Code: NCT03860883

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)

for
Diffuse Large B-Cell Lymphoma
Location: Mobile AL, Jackson MS, Alexandria LA, Athens GA,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06717347

Phase 3, Recruiting

Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)

for
Malignant Female Reproductive System Neoplasm,
Location: Mobile AL, Birmingham AL, Nashville TN, Houston TX,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06126276

Phase 2, Recruiting

DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers

for
Small Cell Lung Carcinoma, Neuroendocrine Neoplasms,
Location: Mobile AL, Tampa FL, Jacksonville FL, Lexington KY,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT05882058

Phase 2, Recruiting

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

for
Triple-Negative Breast Cancer
Location: Mobile AL, Jackson MS, Alexandria LA, Germantown TN,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06393374

Phase 3, Recruiting

A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)

for
Follicular Lymphoma
Location: Mobile AL, Hattiesburg MS, Newnan GA, Marietta GA,
Sponsor: Celgene

Sex: All

Age: 18+

Code: NCT06911502

Phase 3, Recruiting

A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)

for
Lymphoma, Large B-Cell, Diffuse
Location: Mobile AL, New Orleans LA, Baton Rouge LA, Monroe LA,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06890884

Phase 2, Recruiting

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

for
Recurrent Lung Non-Small Cell Carcinoma,
Location: Daphne AL, Saraland AL, Mobile AL, Fairhope AL,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 0+

Code: NCT06031688

Phase 2, Recruiting

MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)

for
Multiple Myeloma
Location: Mobile AL, Nashville TN, Houston TX, The Woodlands TX,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT06152575

Phase 3, Recruiting

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

for
Recurrent Lung Non-Small Cell Carcinoma,
Location: Daphne AL, Saraland AL, Mobile AL, Fairhope AL,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT06616584

Phase 2, Phase 3, Recruiting

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

for
Locally Advanced Lung Non-Small Cell Carcinoma,
Location: Daphne AL, Saraland AL, Mobile AL, Fairhope AL,
Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT05624996

Phase 3, Recruiting

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

for
Recurrent Lung Non-Small Cell Carcinoma,
Location: Daphne AL, Saraland AL, Mobile AL, Fairhope AL,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT05642572

Phase 2, Recruiting

Zero Degree Head Positioning in Hyperacute Large Artery Ischemic Stroke

for
Ischemic Stroke
Location: Mobile AL, Memphis TN, Houston TX, Louisville KY,
Sponsor: University of Tennessee

Sex: All

Age: 18+

Code: NCT03728738

Phase 3, Recruiting

Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure

for
Heart Failure - NYHA II - IV
Location: Mobile AL, Huntsville AL, Atlanta GA, Nashville TN,
Sponsor: Boston Scientific Corporation

Sex: All

Age: 18+

Code: NCT07069738

Recruiting

A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

for
Acral Lentiginous Melanoma,
Location: Mobile AL, Fairhope AL, Birmingham AL, Tampa FL,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT04511013

Phase 2, Recruiting

Decellularized Femoral Artery Allograft (Nexeon AVX) Prospective Registry

for
End-Stage Renal Disease
Location: Mobile AL, Norfolk VA, Torrance CA, Sylmar CA
Sponsor: LifeNet Health

Sex: All

Age: 18+

Code: NCT05880537

Recruiting